Dr. Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award
Assistant Specialist at University of California Irvine Medical Center, United States
Dr. Fatemeh Tajik is an accomplished medical researcher dedicated to advancing cancer diagnostics. She earned her MD in 2021, ranking among the top 1% of her class. Since then, she has been engaged in groundbreaking research on cancer biomarkers, particularly circulating extracellular vesicle biomarkers for peritoneal carcinomatosis. Currently serving as an Assistant Specialist at the University of California, Irvine, Dr. Tajik contributes significantly to translational and clinical research, with the goal of improving patient outcomes.
Profile
Education 🎓
Dr. Tajik completed her Doctor of Medicine (MD) in 2021. Her academic excellence placed her among the top 1% of her graduating class. Her advanced studies and research focus on cancer biomarker identification, leading to significant contributions in oncology.
Experience 🌟
From 2021 to 2023, Dr. Tajik dedicated her research to identifying novel cancer biomarkers, culminating in multiple peer-reviewed publications. In 2023, she joined the Department of Surgery at the University of California, Irvine, where she specializes in translational cancer research. Additionally, she serves as a reviewer for esteemed journals and has co-authored a book chapter, further demonstrating her expertise and commitment to the field.
Research Interests 🌿
Dr. Tajik’s research revolves around cancer biology, with a specific focus on:
- Cancer biomarkers
- Extracellular vesicles
- Peritoneal carcinomatosis Her work aims to refine predictive and prognostic tools for cancer, significantly impacting early detection and treatment approaches.
Awards 🏆
Dr. Tajik has been recognized for her contributions to cancer research and innovation. She has been nominated for prestigious awards such as the Excellence in Research Award and the Best Researcher Award, highlighting her significant impact on the field.
Publications 📚
Dr. Tajik has published extensively in high-impact journals. Her notable publications include:
“Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis”
- Journal: Cancers
- Publication Date: January 17, 2025
- DOI: 10.3390/cancers17020289
“Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease”
- Journal: Journal of Gastrointestinal Cancer
- Publication Date: June 2024
- DOI: 10.1007/s12029-023-00994-5
“Transformation of Chronic Lymphocytic Leukemia into Acute Mixed Phenotype Leukemia Myeloid/T Neoplasm: a Case Report”
- Journal: SN Comprehensive Clinical Medicine
- Publication Date: September 11, 2023
- DOI: 10.1007/s42399-023-01567-0
“Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis”
- Journal: BMJ Supportive & Palliative Care
- Publication Date: June 2023
- DOI: 10.1136/bmjspcare-2021-003125
“A comprehensive Examination of the potential application of Chat GPT in Higher Education Institutions”
- Type: Preprint
- Publication Date: April 12, 2023
- DOI: 10.36227/techrxiv.22589497.v1
“Post-COVID-19 rhinocerebral mucormycosis, a life-threatening event in the background of immunosuppressive condition: A case report”
- Type: Preprint
- Publication Date: January 27, 2023
- DOI: 10.21203/rs.3.rs-2516078/v1
“Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends”
- Journal: Journal of Surgical Oncology
- Publication Date: 2023
- DOI: 10.1002/jso.27448
“Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis”
- Journal: Cancer Cell International
- Publication Date: 2023
- DOI: 10.1186/s12935-023-02851-8
“Clinical significance of CD166 and HER-2 in different types of gastric cancer”
- Journal: Clinical and Translational Oncology
- Publication Date: 2023
- DOI: 10.1007/s12094-023-03297-0
“COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review”
- Journal: BMJ Supportive and Palliative Care
- Publication Date: 2023
- DOI: 10.1136/spcare-2023-004310
Conclusion 🏅